KENTARO IDE

Last Updated :2024/04/03

Affiliations, Positions
Hiroshima University Hospital(Medical), Associate Professor or Lecturer
E-mail
idekenhiroshima-u.ac.jp
Other Contact Details
1-2-3, Kasumi, Minami-ku, Hiroshima, 734-8551, JAPAN, Japan
TEL : (+81)082-257-522 FAX : (+81)082-257-522
Self-introduction
Surgeon, Kidney transplant, Kidney, Desensitization therapy, ABO-incompatible, HLA, Immunosuppressive therapy, Hepatobiliary and pancreatic surgery, Liver transplant, Pancreas transplant, Sepsis, CMV

Basic Information

Major Professional Backgrounds

  • 2008/03/01, 2008/08/31, Hiroshima University Hospital, Clinical Fellow
  • 2008/09/01, 2019/04/30, Hiroshima University Hospital, Assistant Professor
  • 2014/04/01, Hiroshima University, Lecturer
  • 2019/05/01, Hiroshima University, Hospital, Lecturer

Educational Backgrounds

  • Hiroshima University, Japan, 1991/04, 1997/03
  • Hiroshima University, Japan, 2003/04, 2007/03

Academic Degrees

  • Doctor of Philosophy in Medical Science, Hiroshima University

Educational Activity

  • [Bachelor Degree Program] School of Medicine : Program of Medicine : Medicine

In Charge of Primary Major Programs

  • Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical surgery;General surgery

Affiliated Academic Societies

  • Japan Surgical Society
  • The Japanese Society of Gastroenterological Surgery
  • The Japan Society for Transplantation
  • Japanese Society for Clinical Renal Transplantation
  • Japanese Liver Transplantation Society
  • The Japan Society for Organ Preservation and Biology
  • The Japanese Society for Dialysis Therapy
  • Japanese Society of Pathophysiology in Kidney Failure

Educational Activity

Course in Charge

  1. 2024, Undergraduate Education, Intensive, Practice of Medicine I
  2. 2024, Undergraduate Education, Intensive, Practice of Medicine II
  3. 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Gastroenterological and Transplant Surgery
  4. 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Gastroenterological and Transplant Surgery
  5. 2024, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Gastroenterological and Transplant Surgery
  6. 2024, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Gastroenterological and Transplant Surgery

Research Activities

Academic Papers

  1. A phased desensitization protocol with rituximab and bortezomib for highly sensitized kidney transplant candidates., TRANSPLANTATION DIRECT, 201506
  2. B cell depletion with anti-CD20 mAb exacerbates anti-donor CD4(+) T cell responses in highly sensitized transplant recipients, SCIENTIFIC REPORTS, 11(1), 20210913
  3. Molecular Mismatch Predicts T Cell-Mediated Rejection and De Novo Donor-Specific Antibody Formation After Living Donor Liver Transplantation, LIVER TRANSPLANTATION, 27(11), 1592-1602, 202111
  4. Polymorphisms in CTLA-4 predict de novo donor specific antibody formation after kidney transplantation, HUMAN IMMUNOLOGY, 83(6), 494-498, 202206
  5. A case of gastric cancer following living donor liver transplantation., HIROSHIMA JOURNAL OF MRDICAL SCIENCES, 63(1), 23-26, 2014
  6. Pancreaticoduodenectomy with preservation of gastric tube blood flow after esophagectomy: Report of a case. , INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 5(10), 746-749, 2014
  7. Multiple Hepatic Vein Reconstruction Using an All-in-one Sleeve Patch Graft Technique in Living Donor Liver Transplantation: A Case Report, TRANSPLANTATION PROCEEDINGS, 46(3), 982-985, 201404
  8. Risk Factors for Development of New-Onset Diabetes Mellitus and Progressive Impairment of Glucose Metabolism After Living-Donor Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 46(3), 865-869, 201404
  9. Clinical Efficacy of Simultaneous Splenectomy in Liver Transplant Recipients With Hepatitis C Virus, TRANSPLANTATION PROCEEDINGS, 46(3), 770-773, 201404
  10. Potential Benefit of Mixed Lymphocyte Reaction Assay-based Immune Monitoring After Living Donor Liver Transplantation for Recipients With Autoimmune Hepatitis, TRANSPLANTATION PROCEEDINGS, 46(3), 785-789, 201404
  11. Bile CXC Motif Chemokine 10 Levels Correlate With Anti-donor Cytotoxic T Cell Responses After Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 46(3), 790-793, 201404
  12. Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantation, HEPATOLOGY RESEARCH, 44(12), 1259-1264, 201411
  13. Surgical treatment for portosystemic encephalopathy in patients with liver cirrhosis: Occlusion of portosystemic shunt in combination with splenectomy, HEPATOLOGY RESEARCH, 43(3), 249-254, 201303
  14. Expression of Recipient CD47 on Rat Insulinoma Cell Xenografts Prevents Macrophage-Mediated Rejection through SIRP alpha Inhibitory Signaling in Mice, PLOS ONE, 8(3), 20130305
  15. Controlling the bleeding of jejunal varices formed at the site of choledochojejunostomy: report of 2 cases and a review of the literature, SURGERY TODAY, 43(5), 550-555, 201305
  16. Attenuation of Portal Hypertension by Continuous Portal Infusion of PGE1 and Immunologic Impact in Adult-to-Adult Living-Donor Liver Transplantation, TRANSPLANTATION, 95(12), 1521-1527, 20130627
  17. Inferior vena cava tumor thrombus that directly infiltrated from paracaval lymph node metastases in a patient with recurrent hepatocellular carcinoma, WORLD JOURNAL OF SURGICAL ONCOLOGY, 11, 20130806
  18. Optimization of Immunosuppressive Therapy Based on a Multiparametric Mixed Lymphocyte Reaction Assay Reduces Infectious Complications and Mortality in Living Donor Liver Transplant Recipients, TRANSPLANTATION PROCEEDINGS, 44(2), 555-559, 201203
  19. Complex Vascular Reconstruction Using Donor's Vessel Grafts in Orthotopic Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 44(2), 574-578, 201203
  20. Incidental renal cell carcinoma presenting in a renal transplant recipient with autosomal dominant polycystic kidney disease: a case report., JOURNAL OF MEDICAL CASE REPORT, 13(6), 154, 20120601
  21. Safety and Feasibility of Diet-Treated Donors With Steatotic Livers at the Initial Consultation for Living-Donor Liver Transplantation, TRANSPLANTATION, 93(10), 1024-1030, 20120527
  22. Renal Vein Extension Using an Autologous Renal Vein in a Living Donor With Double Inferior Vena Cava: A Case Report, TRANSPLANTATION PROCEEDINGS, 44(5), 1446-1449, 201206
  23. Kinetics of Cellular and Humoral Immunity in a Successful Case of Positive Crossmatch Kidney Transplantation: A Case Report, TRANSPLANTATION PROCEEDINGS, 43(6), 2411-2414, 2011
  24. Long-Term Outcome of Hepatic Artery Reconstruction during Living-Donor Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 43(5), 1720-1724, 201106
  25. Evidence for the immunosuppressive potential of calcineurin inhibitor-sparing regimens in liver transplant recipients with impaired renal function., JOURNAL OF TRANSPLANTATION, 483728, 20110601
  26. Impact of Adjuvant Immunotherapy Using Liver Allograft-Derived Lymphocytes on Bacteremia in Living-Donor Liver Transplantation, TRANSPLANTATION, 92(5), 575-580, 201109
  27. Human CD47 Expression Permits Survival of Porcine Cells in Immunodeficient Mice That Express SIRP alpha Capable of Binding to Human CD47, CELL TRANSPLANTATION, 20(11-12), 1915-1920, 2011
  28. Determination of the precursor frequency and the reaction intensity of xenoreactive human T lymphocytes., XENOTRANSPLANTATION, 17(3), 188-196, 20100501
  29. Immunological Property of Antibodies against N-Glycolylneuraminic Acid Epitopes in Cytidine Monophospho-N-Acetylneuraminic Acid Hydroxylase-Deficient Mice, JOURNAL OF IMMUNOLOGY, 184(6), 3269-3275, 20100315
  30. Deficiency of N-glycolylneuraminic acid and Gal alpha 1-3Gal beta 1-4GlcNAc epitopes in xenogeneic cells attenuates cytotoxicity of human natural antibodies, XENOTRANSPLANTATION, 17(6), 440-448, 2010
  31. Significant Correlation Between Spleen Volume and Thrombocytopenia in Liver Transplant Patients: A Concept for Predicting Persistent Thrombocytopenia, LIVER TRANSPLANTATION, 15(2), 208-215, 200902
  32. ABO-blood type incompatible living donor liver transplantation in a patient with Budd-Chiari Syndrome secondary to essential thrombocythemia, HEPATOLOGY RESEARCH, 39(5), 520-524, 200905
  33. Successful hepatitis B vaccination in liver transplant recipients with donor-specific hyporesponsiveness, TRANSPLANT INTERNATIONAL, 22(8), 805-813, 200908
  34. Surgical techniques for prevention of recurrence after total enterolysis in encapsulating peritoneal sclerosis., Adv Perit Dial., 24, 51-55, 20080401
  35. Prophylaxis against recurrence of HBV hepatitis after living-donor liver transplantation., HEPATOGASTROENTEROLOGY, 55(86-87), 1746-1749, 20080901
  36. Recommendation of the surgical option for treatment of encapsulating peritoneal sclerosis., Perit Dial Int., 28, S205-210, 20080601
  37. ★, Role for CD47-SIRP alpha signaling in xenograft rejection by macrophages, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 104(12), 5062-5066, 20070320
  38. Possible therapeutic effect of lipid supplementation on neurological complications in liver transplant recipients, TRANSPLANT INTERNATIONAL, 20(7), 632-635, 200707
  39. Microsurgical hepatic artery reconstruction during living-donor liver transplantation by using head-mounted surgical binocular system, TRANSPLANT INTERNATIONAL, 20(11), 970-973, 200711
  40. The persistent elimination of B cells responding to blood group A carbohydrates by synthetic group A carbohydrates and B-1 cell differentiation blockade: novel concept in preventing antibody-mediated rejection in ABO-incompatible transplantation, BLOOD, 110(13), 4567-4575, 20071215
  41. Liver sinusoidal endothelial cells that endocytose allogeneic cells suppress T cells with indirect allospecificity, JOURNAL OF IMMUNOLOGY, 177(6), 3615-3624, 20060915
  42. Antibody- and complement-independent phagocytotic and cytolytic activities of human macrophages toward porcine cells, XENOTRANSPLANTATION, 12(3), 181-188, 200505
  43. Liver sinusoidal endothelial cells tolerize T cells across MHC barriers in mice, JOURNAL OF IMMUNOLOGY, 175(1), 139-146, 20050701
  44. Vascular closure staples for portal vein reconstruction in living-donor liver transplantation, AMERICAN JOURNAL OF SURGERY, 190(1), 65-68, 200507
  45. Successful resolution of very severe hepatopulmonary syndrome following adult-to-adult living donor liver transplantation: Report of two cases, HEPATOLOGY RESEARCH, 45(9), 1041-1046, 201509
  46. Treatment of hepatic amyloid light-chain amyloidosis with bortezomib and dexamethasone in a liver transplant patient, HEPATOLOGY RESEARCH, 45(10), E150-E155, 201510
  47. Fc-Gamma Receptor Polymorphisms Predispose Patients to Infectious Complications After Liver Transplantation, AMERICAN JOURNAL OF TRANSPLANTATION, 16(2), 625-633, 201602
  48. Intraoperative assessment of tissue oxygen saturation of the remnant stomach by near-infrared spectroscopy in two cases of pancreatectomy following gastrectomy, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 22, 75-78, 2016
  49. Inflammatory pseudotumor of the liver occurring during the course of hepatitis C virus-related hepatocellular carcinoma treatment: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 20, 96-100, 2016
  50. Different sensitivity of rituximab-treatment to B-cells between ABO-incompatible kidney and liver transplantation, HUMAN IMMUNOLOGY, 77(6), 456-463, 201606
  51. Stepwise approach to curative surgery using percutaneous transhepatic cholangiodrainage and portal vein embolization for severe bile duct injury during laparoscopic cholecystectomy: a case report, SURGICAL CASE REPORTS, 2, 20160317
  52. Three patients treated with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation: Case report, HEPATOLOGY RESEARCH, 46(7), 707-712, 201606
  53. Prediction of long-term survival by using the Glasgow Prognostic Score in patients with hepatocellular carcinoma after liver transplantation, HEPATOLOGY RESEARCH, 46(7), 622-633, 201606
  54. Intrahepatic cholangiocarcinoma coinciding with a liver metastasis from a rectal carcinoma: a case report, SURGICAL CASE REPORTS, 2, 20160909
  55. Pseudolymphoma of the liver: a case report and literature review., SURGICAL CASE REPORTS, 1(107), 2015
  56. Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis C: pilot study, JOURNAL OF VIRAL HEPATITIS, 23(11), 850-856, 201611
  57. MELD and Child-Pugh Scores Are Related to Immune Status of Intrahepatic Natural Killer Cells in Liver Transplant Candidates, TRANSPLANTATION PROCEEDINGS, 49(1), 98-101, 2017
  58. Efficacy of repeat hepatectomy for recurrence following curative hepatectomy for colorectal liver metastases: A Retrospective Cohort Study of 128 patients, INTERNATIONAL JOURNAL OF SURGERY, 36, 96-103, 201612
  59. Elective laparoscopic deroofing to treat the spontaneous rupture of a large simple liver cyst: a case report, SURGICAL CASE REPORTS, 2, 20161207
  60. Fc-gamma receptor 3A polymorphism predicts the incidence of urinary tract infection in kidney-transplant recipients., HUMAN IMMUNOLOGY, 78(4), 357-362, 201704
  61. Predictive Independent Factors for Extrahepatic Metastasis of Hepatocellular Carcinoma Following Curative Hepatectomy, ANTICANCER RESEARCH, 37(5), 2625-2631, 201705
  62. Biliary-duodenal anastomosis using magnetic compression following massive resection of small intestine due to strangulated ileus after living donor liver transplantation: a case report, SURGICAL CASE REPORTS, 3, 20170525
  63. Significance of the Glasgow Prognostic Score for patients with colorectal liver metastasis, INTERNATIONAL JOURNAL OF SURGERY, 42, 209-214, 201706
  64. Kidney transplantation from an anti-hepatitis C virus antibody-positive donor into an anti-hepatitis C virus antibody-negative recipient: A case report., Transplantation Reports, 1, 4-6, 2016
  65. Central bisectionectomy for hepatocellular carcinoma in a patient with indocyanine green excretory defect associated with reduced expression of the liver transporter., SURGICAL CASE REPORTS, 2(1), 89, 2016
  66. Efficacy and Feasibility of Salvage Living Donor Liver Transplantation after Initial Liver Resection in Patients with Hepatocellular Carcinoma, Digestive Surgery, 33(1), 8-14
  67. Aggressive angiomyxoma of the liver: a case report and literature review., SURGICAL CASE REPORTS, 3(1), 92, 2017
  68. Effect of Fc-gamma Receptor Polymorphism on Rituximab-Mediated B Cell Depletion in ABO-Incompatible Adult Living Donor Liver Transplantation., TRANSPLANTATION DIRECT, 2017
  69. Acute Graft Rejection and Formation of De Novo Donor-Specific Antibodies Triggered by Low Cyclosporine Levels and Interferon Therapy for Recurrent Hepatitis C Infection After Liver Transplantation: A Case Report, TRANSPLANTATION PROCEEDINGS, 49(7), 1634-1638, 201709
  70. Perforation of the gallbladder in a patient with acute cytomegalovirus cholecystitis shortly following renal transplantation, TRANSPLANT INFECTIOUS DISEASE, 19(5), 201710
  71. Perioperative management with phosphodiesterase type 5 inhibitor and prostaglandin E1 for moderate portopulmonary hypertension following adult-to-adult living-donor liver transplantation: a case report, SURGICAL CASE REPORTS, 4, 20180207
  72. Utility of hepatobiliary scintigraphy for recurrent reflux cholangitis following choledochojejunostomy: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 42, 104-108, 2018
  73. A case report on the successful perioperative management of hepatectomy for hepatocellular carcinoma in a patient with von Willebrand disease, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 44, 131-134, 2018
  74. Hepatectomy versus stereotactic body radiotherapy for primary early hepatocellular carcinoma: A propensity-matched analysis in a single institution, SURGERY, 164(2), 219-226, 201808
  75. Impact of Abdominal Aortic Calcification among Liver Transplant Recipients: A Retrospective Study., Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2018
  76. Independent risk factors that predict bile leakage after hepatectomy for hepatocellular carcinoma: Cohort study, INTERNATIONAL JOURNAL OF SURGERY, 57, 1-7, 201809
  77. Impact of Abdominal Aortic Calcification Among Liver Transplantation Recipients, LIVER TRANSPLANTATION, 25(1), 79-87, 201901
  78. A rare case of transient left ventricular apical ballooning syndrome following living donor liver transplantation: A case report and literature review, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 55, 218-222, 2019
  79. Risk Factors for Refractory Ascites After Living Donor Liver Transplant, TRANSPLANTATION PROCEEDINGS, 51(5), 1516-1519, 201906
  80. Simultaneous Liver-Kidney Transplantation in Patient with a History of Heparin-Induced Thrombocytopenia: A Case Report and Literature Review, AMERICAN JOURNAL OF CASE REPORTS, 20, 980-987, 20190709
  81. A case of biliary cystic tumor with repeated hemobilia., Surgical case reports, 1(1), 2015
  82. Alcohol Use Disorders Identification Test-consumption Predicts the Risk of Excessive Alcohol Consumption After Liver Transplantation, TRANSPLANTATION PROCEEDINGS, 51(6), 1934-1938, 2019
  83. Management of Refractory Ascites for Liver Transplant Candidates: A Novel Cell-free and Concentrated Ascites Reinfusion Therapy, TRANSPLANTATION PROCEEDINGS, 51(8), 2740-2744, 201910
  84. Utility of Doppler Ultrasonography in Liver Transplantation With Celiac Axis Compression Syndrome: A Case Report, TRANSPLANTATION PROCEEDINGS, 51(9), 3103-3106, 201911
  85. Hepatic epithelioid hemangioendothelioma successfully treated with living donor liver transplantation: A case report and literature review, CLINICAL CASE REPORTS, 8(1), 108-115, 202001
  86. Successful Treatment of Chronic Myeloid Leukemia With Dasatinib After Kidney Transplantation: A Case Report, TRANSPLANTATION PROCEEDINGS, 52(2), 600-603, 202003
  87. A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis in Heart and Kidney Transplant Recipients in Japan, TRANSPLANTATION, 104(2), 437-444, 202002
  88. Strategies for Deliberate Induction of Immune Tolerance in Liver Transplantation: From Preclinical Models to Clinical Application, FRONTIERS IN IMMUNOLOGY, 11, 20200731
  89. Obliteration of a Portosystemic Shunt by Hybrid Interventional Radiology Using a Transmesenteric Approach Under Minilaparotomy After Liver Transplantation: A Case Report, TRANSPLANTATION PROCEEDINGS, 52(9), 2762-2766, 202011
  90. Rapidly Progressive Invasive Urothelial Carcinoma With Flat and Infiltrative Growth Pattern in the Graft Kidney After Living-Related Kidney Transplantation: A Case Report, TRANSPLANTATION PROCEEDINGS, 52(9), 2726-2730, 202011
  91. Impact on biliary complications of donor abdominal aortic calcification among living donor liver transplantation: a retrospective study, TRANSPLANT INTERNATIONAL, 33(12), 1745-1753, 202012
  92. Analysis of Risk Factors Affecting Incidence of Osteoporosis and Fragility Fractures in Liver Transplant Recipients, ANNALS OF TRANSPLANTATION, 26, 20210205
  93. Development of a humanized mouse model to analyze antibodies specific for human leukocyte antigen (HLA), PLOS ONE, 16(2), 20210205
  94. Loss of antibodies to hepatitis E virus in organ transplant patients with hepatitis E, HEPATOLOGY RESEARCH, 51(5), 538-547, 202105
  95. Peritoneal lavage with hydrogen-rich saline can be an effective and practical procedure for acute peritonitis, SURGERY TODAY, 51(11), 1860-1871, 202111
  96. Treatment of multiple huge liver cysts in a hybrid operating room: a case report, SURGICAL CASE REPORTS, 7(1), 20211029
  97. Impact of abdominal aortic calcification on clinical outcomes following initial hepatectomy for hepatocellular carcinoma: A retrospective cohort study, ANNALS OF GASTROENTEROLOGICAL SURGERY, 6(1), 149-158, 202201

Invited Lecture, Oral Presentation, Poster Presentation

  1. A PHASED DESENSITIZATION PROTOCOL WITH RITUXIMAB AND BORTEZOMIB FOR HIGHLY HLA-SENSITIZED KIDNEY TRANSPLANT CANDIDATES, KENTARO IDE, CONGRESS OF THE ASIAN SOCIETY OF TRANSPLANTATION 2015, 2015/08/25, Without Invitation, English, Singapore
  2. Assessment using a novel predictive value and treatment for steroid-resistant acute cellular rejection after liver transplantation, Tahara H, Ishiyama K, Ide K, Tanaka Y, Ohira M, Tanimine N, Shimizu S, Kobayashi T, Ohdan H, Transplantation Science Symposium Asian Regional Meeting 2016, 2016/04/08, Without Invitation, English
  3. Significant association of Innate Immune Related Genes Polymorphism on Infectious Complications Following Early Post Renal Transplantation Phase., Das Lalit Kumar K.Ide, Y.Tanaka, S.Shimizu, N.Tanimine, S.Verma, H.Ohdan, American Transplant Congress 2016, 2016/06/11, Without Invitation, English
  4. Immunotherapy using donor liver NK cells for preventing severe infection after liver transplantation, 2016/07/13, Without Invitation, English
  5. A novel paradigm to treat CNI-resistant AMR induced by bacterial pathogen via TLR pathway in B cells, 2016/07/13, Without Invitation, English
  6. Cotransplantation of preactivated mesenchymal stem cells inhibits liver natural killer cell–induced islet graft injury during instant blood-mediated inflammatory reaction after syngeneic intraportal islet transplantation, Ishida N Ohdan H, Ishiyama K, Saeki Y, Tanaka Y, Tahara H, Verma S, Saparbay D, Sasaki Y, Onoe T, Ohira M, Yano T, Yanagawa S, Taguchi K, Piao J, Tanaka A, Ide K, Shimizu S, Das L K, Nakano R., 26th International Congress of the Transplantation Society, 2016/08, Without Invitation, English
  7. Different sensitivity of rituximab-treatment to B-cells between ABO-incompatible kidney and liver transplantation., Tanaka A Morimoto H, IdeK, Tanaka Y, Ishiyama K, Ohira M, Tahara H, Shimizu S, Saeki Y, Sakai H, Tano T, Ishida N, Yanagawa S, Tagushi K, Nakano R, Ohdan H., 26th International Congress of the Transplantation Society, 2016/08/18, Without Invitation, English
  8. Comparison of anti-donor immune response in recipients after kidney and pancreas-kidney transplantation, Kohei Ishiyama Nobuki Ishida, Kentaro Ide, Yuka Tanaka, Hideki Ohdan, Asian Transplantation Week 2016, 2016/10/27, Without Invitation, English
  9. Current status of desensitization protocol for highly HLA-sensitized kidney transplant candidates, Kentaro Ide, Hiroyuki Tahara, Asuka Tanaka, Shuji Akimoto, Sapana Verma, Lalit Kumar Das, Seiichi Shimizu, Masahiro Ohira, Kohei Ishiyama, Yuka Tanaka, Hideki Ohdan, 2017/02/15, Without Invitation, English
  10. Evaluation of Immunological States of Patients with Cytomegalovirus Infection After Kidney Transplantation, Tanaka A, Kentaro Ide, Yuka Tanaka, Kohei Ishiyama, Masahiro Ohira, Hiroyuki Tahara, Seiichi Shimizu, Das Lalit Kumar and Hideki Ohdan, American Transplant Congress 2017, 2017/04, Without Invitation, English
  11. The 3D Printing Liver Model Contributes Navigation of Anatomical Hepatic Resection, Kuroda S, Kobayashi T, Ishiyama K, Ide K, Ohira M, Tahara H, Shimizu S, Nikawa H, Ohdan H, 2017/06, Without Invitation, English
  12. Prognosis after liver resection for intermediate stage hepatocellular carcinoma, Okimoto.S, Kobayashi T, Kudora S, Ishiyama K, Ide K, Ohira M, Tahara H, Shimizu S, Ohdan H, 2017/06, Without Invitation, English
  13. Anatomical hepatectomy with the midline incision for right-sided liver tumors, Kobayashi T, Sho Okimoto, Shintaro Kuroda,Michinori Hamaoka,Seiichi Shimizu,Hiroyuki Tahara,Masahiro Ohira,Kentaro Ide,Kohei Ishiyama,Hideki Ohdan, 2017/06, Without Invitation, English
  14. Fcg receptor polymorphism influences the effect of rituximab on B-cell depletion in ABO-incompatible adult living donor liver transplantation, Sakai H, Yuka Tanaka, Seiichi Shimizu, Kentaro Ide, Kohei Ishiyama, Takashi Onoe, Masahiro Ohira, Hiroyuki Tahara, Tsuyoshi Kobayashi and Hideki Ohdan, 2017/06, Without Invitation, English
  15. Approaches to improve pancreas transplant outcome at Hiroshima University, Kohei Ishiyama, Hiroyuki Tahara, Masahiro Ohira, Kentaro Ide, Tsuyoshi Kobayashi, Yuka Tanaka, Hideki Ohdan, 2017/06, Without Invitation, English
  16. The management for portal vein thrombosis stenosis in liver transplantation, Seiichi Shimizu, Takashi Onoe, Hirotaka Tashiro, Kohei Ishiyama, Kentaro Ide, Masahiro Ohira, Hiroyuki Tahara, Tsuyoshi Kobayashi, Shintaro Kuroda, and Hideki Ohdan, 2017/06, Without Invitation, English
  17. Effect of desensitization with rituximab on anti-donor T-cell responses in HLA-sensitized liver transplant recipients, Ide.K, Tanaka.Y, Tahara.H, Ohira.M, Shimizu.S, Ohdan.H, Asian Transplantation Week 2017(ATW 2017), 2017/10/18, Without Invitation, English, Korea
  18. B-cell depletion with rituximab exacerbates anti-donor CD4+ T-Cell responses in patients with donor-specific anti-human leukocyte antigen antibodies, Kentaro Ide, Yuka Tanaka, Hiroyuki Tahara, Masahiro Ohira, Seiichi Shimizu, Asuka Tanaka, Hideki Ohdan, 27th International Congress of the Transplantation Society, 2018/06, Without Invitation, English
  19. INVESTIGATION OF FACTORS AFFECTING PERIOPERATIVE NUTRITIONAL STATUS IN KIDNEY TRANSPLANTATION, Akimoto S, Tahara H, Akhmet Seidakhmetov,Yamane H,Sato K,Imaoka Y,Honmyo N,Nakashima I,Taguchi K,Tanaka A,Jamilya Saparbay,Doskali Marlen, Hashimoto S,Ohira M,Ide K,Tanaka Y,Ohdan H, 19th Congress of the Euuropean Society for Organ Transplantation, 2019/09, Without Invitation, English
  20. Class II HLA Eplet mismatch is a risk factor for de novo Donor-Specific antibody development in kidney transplantation recipient., Yamane H, Tanaka Y,Ono K,Ohira M,Tahara H,Ide K,Ohdan H, 19th Congress of the Euuropean Society for Organ Transplantation, 2019/09, Without Invitation, English
  21. Safety and efficacy of novel cell-free and concentrated ascites reinfusion therapy (KM-CART) for refractory ascites in liver transplant candidates, Sato K, Ohira M,Imaoka Y,Hashimoto S,Tahara H,Ide K,Kobayashi T,Tanaka Y,Ohdan H, 19th Congress of the Euuropean Society for Organ Transplantation, 2019/09, Without Invitation, English
  22. Adjuvant immunotherapy for liver transplant recipients with hepatocellular carcinoma using donor liver derived natural killer cells, Ohira M, Ryuichi Hotta, Yuki Imaoka, Koki Sato, Hiroyuki Tahara, Kentaro Ide, Tsuyoshi Kobayashi, Yuka Tanaka, Andreas G Tzakis, Seigo Nishida, Hideki Ohdan, American Transplant Congress 2020, 2020/05/30, Without Invitation, English
  23. Association with acute kidney injury and chronic kidney disease after liver transplantation, Ide R, Masahiro Ohira, Hiroshi Morimoto, Shintaro Kuroda, Hiroyuki Tahara, Kentaro Ide, Tsuyoshi Kobayashi, Yuka Tanaka, Hideki Ohdan, American Transplant Congress 2020, 2020/05/30, Without Invitation, English
  24. Minimum incision open donor nephrectomy versus laparoendoscopic single-site donor nephrectomy: A possible safe alternative., Kentaro Ide, Masahiro Ohira, Hiroyuki Tahara, Asuka Tanaka, Hideki Ohdan, 28th International Congress of The Transplantation Society, 2020/09/13, Without Invitation, English
  25. B cell depletion with rituximab exacerbates anti-donor CD4+ T-Cell responses in highly sensitized transplant model, Asuka Tanaka, Kentaro Ide, Yuka Tanaka, Masahiro Ohira, Hiroyuki Tahara, Hiroshi Morimoto, Hideki Ohdan, 28th International Congress of The Transplantation Society, 2020/09/13, Without Invitation, English
  26. Class II HLA eplet mismatch is related to anti-donor CD4+ T cell response and de novo donor-specific antibody development in kidney transplantation recipient, Hiroaki Yamane, Yuka Tanaka, Masahiro Ohira, Hiroyuki Tahara, Kentaro Ide, Hideki Ohdan., TTS 2020 VIRTUAL, 2020/09/13, Without Invitation, English

External Funds

Acceptance Results of Competitive Funds

  1. KAKENHI(Grant-in-Aid for Scientific Research (C)), 2017, 2019
  2. 2016
  3. 2016
  4. KAKENHI, 2014, 2016
  5. 2013, 2013
  6. KAKENHI, The conquest of anti NeuGc antibody mediated xenogeneic islet rejection through CD47-SIRPα signaling., 2011, 2012
  7. KAKENHI, The CD47-SIRPa signaling blockade accelerates macrophage phagocytic activity against cancer cells, 2011, 2013
  8. 2009, 2010
  9. KAKENHI, 2009, 2010
  10. KAKENHI, Strategy of macrophage-mediated xenograft rejection through inhibitory signaling to SIRP., 2008, 2009
  11. KAKENHI, Inhibition of xeno-antigen reactive T cells and B cells by regulation of CD47-SIRP signaling, 2008, 2010
  12. 2008, 2008
  13. 2005, 2005